Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Ye

Showing results (541-550 of 563) with videos related to

Pageof 57
Sort By:
Science Advances|January 26, 2022
Tumor suppressor CEBPA interacts with and inhibits DNMT3A activityXiufei Chen, Wenjie Zhou, Ren-Hua Song, et al.
Science Advances|April 28, 2023
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapyYu-Jia Chen, Guan-Nan Li, Xian-Jing Li, et al.
Cancer Cell|February 13, 2020
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant CancersDhivya R Sudhan, Angel Guerrero-Zotano, Helen Won, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 21, 2020
Abnormal myocardial expression of SAP97 is associated with arrhythmogenic riskHassan Musa, Cherisse A Marcou, Todd J Herron, et al.
Nature Metabolism|May 23, 2022
Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigeneticsQi Liu, Fangming Zhu, Xinnan Liu, et al.
Cancer Cell|January 25, 2020
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant CancersDhivya R Sudhan, Angel Guerrero-Zotano, Helen Won, et al.
Acta Pharmacologica Sinica|August 16, 2020
Identification and characterization of isocitrate dehydrogenase 1 (IDH1) as a functional target of marine natural product grincamycin BZheng Wang, Zeng-Xia Li, Wen-Cao Zhao, et al.
Annals of Palliative Medicine|August 11, 2021
Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective studyLing Sang, Yin Xi, Zhimin Lin, et al.
Nature|January 20, 2025
Author Correction: R-loop-dependent promoter-proximal termination ensures genome stabilityCongling Xu, Chengyu Li, Jiwei Chen, et al.
Research Square|July 28, 2023
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancerChang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.
Pageof 57

Showing results (541-550 of 563) with videos related to

Sort By:
Pageof 57
Science Advances|January 26, 2022
Tumor suppressor CEBPA interacts with and inhibits DNMT3A activityXiufei Chen, Wenjie Zhou, Ren-Hua Song, et al.
Science Advances|April 28, 2023
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapyYu-Jia Chen, Guan-Nan Li, Xian-Jing Li, et al.
Cancer Cell|February 13, 2020
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant CancersDhivya R Sudhan, Angel Guerrero-Zotano, Helen Won, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 21, 2020
Abnormal myocardial expression of SAP97 is associated with arrhythmogenic riskHassan Musa, Cherisse A Marcou, Todd J Herron, et al.
Nature Metabolism|May 23, 2022
Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigeneticsQi Liu, Fangming Zhu, Xinnan Liu, et al.
Cancer Cell|January 25, 2020
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant CancersDhivya R Sudhan, Angel Guerrero-Zotano, Helen Won, et al.
Acta Pharmacologica Sinica|August 16, 2020
Identification and characterization of isocitrate dehydrogenase 1 (IDH1) as a functional target of marine natural product grincamycin BZheng Wang, Zeng-Xia Li, Wen-Cao Zhao, et al.
Annals of Palliative Medicine|August 11, 2021
Secondary infection in severe and critical COVID-19 patients in China: a multicenter retrospective studyLing Sang, Yin Xi, Zhimin Lin, et al.
Nature|January 20, 2025
Author Correction: R-loop-dependent promoter-proximal termination ensures genome stabilityCongling Xu, Chengyu Li, Jiwei Chen, et al.
Research Square|July 28, 2023
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancerChang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.
Pageof 57